AU2001226926A1 - Dextrin containing compositions for prevention of adhesions - Google Patents

Dextrin containing compositions for prevention of adhesions

Info

Publication number
AU2001226926A1
AU2001226926A1 AU2001226926A AU2692601A AU2001226926A1 AU 2001226926 A1 AU2001226926 A1 AU 2001226926A1 AU 2001226926 A AU2001226926 A AU 2001226926A AU 2692601 A AU2692601 A AU 2692601A AU 2001226926 A1 AU2001226926 A1 AU 2001226926A1
Authority
AU
Australia
Prior art keywords
adhesions
prevention
containing compositions
dextrin containing
dextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001226926A
Other languages
English (en)
Inventor
Susan Conroy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
ML Laboratories PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0001352A external-priority patent/GB0001352D0/en
Priority claimed from GB0015035A external-priority patent/GB2363713A/en
Application filed by ML Laboratories PLC filed Critical ML Laboratories PLC
Publication of AU2001226926A1 publication Critical patent/AU2001226926A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AU2001226926A 2000-01-21 2001-01-19 Dextrin containing compositions for prevention of adhesions Abandoned AU2001226926A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0001352 2000-01-21
GB0001352A GB0001352D0 (en) 2000-01-21 2000-01-21 Prevention of adhesions
GB0015035A GB2363713A (en) 2000-06-21 2000-06-21 Dextrin compositions
GB0015035 2000-06-21
PCT/GB2001/000193 WO2001052866A1 (en) 2000-01-21 2001-01-19 Dextrin containing compositions for prevention of adhesions

Publications (1)

Publication Number Publication Date
AU2001226926A1 true AU2001226926A1 (en) 2001-07-31

Family

ID=26243442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001226926A Abandoned AU2001226926A1 (en) 2000-01-21 2001-01-19 Dextrin containing compositions for prevention of adhesions

Country Status (13)

Country Link
US (1) US8455464B2 (de)
EP (1) EP1248636B1 (de)
JP (1) JP4999247B2 (de)
KR (1) KR100740735B1 (de)
AT (1) ATE299375T1 (de)
AU (1) AU2001226926A1 (de)
CA (1) CA2392666C (de)
DE (1) DE60111921T2 (de)
DK (1) DK1248636T3 (de)
ES (1) ES2245974T3 (de)
HK (1) HK1048433B (de)
PT (1) PT1248636E (de)
WO (1) WO2001052866A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810127D0 (en) * 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
US7737214B2 (en) 2004-03-15 2010-06-15 Terumo Kabushiki Kaisha Adhesion preventive material
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
KR101444291B1 (ko) * 2013-01-16 2014-09-26 경북대학교병원 설페이트 전분을 포함하는 복막투석액용 삼투압제 및 이를 포함하는 복막투석용 조성물
CN111643519A (zh) * 2020-06-29 2020-09-11 华仁药业股份有限公司 一种伤口消毒液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
DE69900648T2 (de) * 1998-05-13 2002-07-04 Ml Lab Plc Blaby Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
PL353232A1 (en) 1999-08-10 2003-11-03 Ml Laboratories Plc Method for delivery of therapeutic agents using a solution of dextrin

Also Published As

Publication number Publication date
KR100740735B1 (ko) 2007-07-19
WO2001052866A1 (en) 2001-07-26
EP1248636B1 (de) 2005-07-13
HK1048433B (zh) 2005-12-23
US20030153529A1 (en) 2003-08-14
HK1048433A1 (en) 2003-04-04
EP1248636A1 (de) 2002-10-16
JP4999247B2 (ja) 2012-08-15
KR20030005160A (ko) 2003-01-17
CA2392666C (en) 2011-12-13
PT1248636E (pt) 2005-11-30
CA2392666A1 (en) 2001-07-26
DE60111921D1 (de) 2005-08-18
ATE299375T1 (de) 2005-07-15
ES2245974T3 (es) 2006-02-01
JP2003520243A (ja) 2003-07-02
DE60111921T2 (de) 2006-07-20
DK1248636T3 (da) 2005-11-07
US8455464B2 (en) 2013-06-04

Similar Documents

Publication Publication Date Title
MY127247A (en) New pharmaceutical composition
AU4659900A (en) Treating compositions comprising polysaccharides
DE60210317D1 (de) Wässrige zusammensetzungen für oberflächebehandlung
MXPA02012206A (es) Composiciones que contienen componentes terapeuticamente activos que tienen solubilidad mejorada.
WO2002072031A3 (en) Substituted tetracycline compounds as synergistic antifungal agents
CA2416823A1 (en) Antimycotic nail varnish composition
AU5294100A (en) Method and compositions for treating the inflammatory response
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
WO2004028474A3 (en) Caspase inhibitors as anticancer agents
MXPA05000785A (es) Composicion y proceso para tratar manchas.
EP1178796A4 (de) Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
AU4797596A (en) Use of hydrofluoroalkenes as cleaning agents, and compositions which may be used for their purpose
AU2001226926A1 (en) Dextrin containing compositions for prevention of adhesions
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
AU2690297A (en) Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination for the production of a pharmaceutical agent for treating a relative and absolute androgen deficiency in men
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
WO2004034961A3 (en) Antimicrobial agents and uses thereof
WO2003086271A3 (en) Azole derivatives as antifungal agents
WO2002062334A3 (en) Cancer chemopreventative compounds and compositions and methods of treating cancers
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
WO2003053365A3 (en) Syn3 compositions and methods
AU2001294062A1 (en) Method of treating aqueous compositions
MY129632A (en) Wood preservative formulations
AU2811400A (en) Stable formulation containing fumagillin